Carin Canale-Theakston insider trades
Open-market stock purchases and sales by Carin Canale-Theakston, Director at Cidara Therapeutics, Inc, from SEC Form 4 filings since Jan 22, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $87.8K |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $33.6K |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $26.9K |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $365K |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $237K |
| Jan 7, 2026 | CDTX Cidara Therapeutics, Inc | Sold (not open market) | $14.8K |
Companies traded
- CDTX Cidara Therapeutics, Inc: other filings, last Jan 7, 2026
Get free alerts when Carin Canale-Theakston files a new trade →